Given the travel and safety regulations in place to combat the coronavirus COVID-19 pandemic, the Johnson & Johnson Innovation team is looking to present its external collaboration model and meet life sciences start-ups across Europe through virtual events and 1:1 sessions. The first such virtual event will target the Swiss ecosystem. The event will include an open briefing on the Johnson & Johnson Innovation model on May 27, followed by one-to-one partnering meetings with selected companies on May 27 and 28.
The largest global biotechnology partnering event.
Exciting races and challenging tasks for pilots and spectators
Featuring leading experts in panels, networking and business development opportunities.